Nabiha Yusuf Selected Research

Melanoma (Melanoma, Malignant)

2/2024	Ultraviolet Radiation Biological and Medical Implications.
9/2023	Modulation of Skin Cancer by the Stimulator of Interferon Genes.
6/2023	The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers.
3/2023	Role of the Microbiome in Immunotherapy of Melanoma.
1/2021	Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.
1/2019	KSRP modulates melanoma growth and efficacy of vemurafenib.
5/2016	A murine model for the development of melanocytic nevi and their progression to melanoma.
7/2013	Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome.
2/2007	Photoprotective effects of green tea polyphenols.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nabiha Yusuf Research Topics

Disease

37	Neoplasms (Cancer) 01/2024 - 03/2004
14	Skin Neoplasms (Skin Cancer) 09/2023 - 02/2007
14	Carcinogenesis 01/2023 - 11/2007
9	Melanoma (Melanoma, Malignant) 02/2024 - 02/2007
8	Inflammation (Inflammations) 10/2021 - 05/2006
4	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 07/2019
3	Neuroinflammatory Diseases 02/2024 - 01/2023
3	Breast Neoplasms (Breast Cancer) 06/2015 - 01/2012
2	Basal Cell Carcinoma (Rodent Ulcer) 06/2023 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2018
2	Infections 01/2018 - 08/2004
2	Contact Dermatitis (Eczema, Contact) 01/2015 - 01/2009
1	Mycosis Fungoides 03/2024
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2024
1	Atopic Dermatitis (Atopic Eczema) 03/2024
1	Photosensitivity Disorders (Photodermatitis) 02/2024
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2024
1	Autoimmune Diseases of the Nervous System 02/2024
1	Immune System Diseases (Immune Disorders) 01/2024
1	Bites and Stings (Sting) 09/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2023
1	Dysbiosis 11/2022
1	Xeroderma Pigmentosum (Kaposi's Disease) 10/2021
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 01/2021
1	Cachexia 11/2018

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 03/2024 - 01/2009
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
6	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2008
5	InterferonsIBA 09/2023 - 03/2011
5	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2021 - 01/2008
5	InterleukinsIBA 01/2021 - 11/2009
4	CarcinogensIBA 02/2022 - 11/2007
4	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017 - 01/2012
4	HydrocarbonsIBA 05/2015 - 11/2007
3	Peptides (Polypeptides)IBA 02/2024 - 10/2018
3	phenethyl isothiocyanate (PEITC)IBA 04/2023 - 01/2021
3	AntioxidantsIBA 02/2023 - 05/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2018
3	Toll-Like Receptor 4IBA 10/2021 - 01/2008
3	Interleukin-12 (IL 12)IBA 01/2021 - 11/2009
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 03/2011
3	baicalinIBA 01/2019 - 11/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 05/2006
2	Matrix Metalloproteinases (MMPs)IBA 02/2024 - 02/2012
2	Interferon LambdaIBA 02/2024 - 06/2023
2	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2023
2	sulforaphaneIBA 04/2023 - 01/2023
2	PhytochemicalsIBA 01/2023 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 07/2019
2	allicinIBA 01/2023 - 05/2006
2	Interferon Type IIBA 02/2022 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	Caspase 3 (Caspase-3)IBA 01/2021 - 10/2011
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2018
2	ChemokinesIBA 11/2018 - 01/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2017 - 11/2009
2	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2017 - 01/2015
2	InflammasomesIBA 01/2017 - 07/2013
2	anthraceneIBA 05/2016 - 03/2004
2	Interleukin-17 ReceptorsIBA 01/2015 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 05/2006
1	MelanocortinsIBA 02/2024
1	Melanins (Melanin)IBA 02/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	CarbonIBA 11/2023
1	IsothiocyanatesIBA 04/2023
1	benzyl isothiocyanateIBA 04/2023
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2023
1	NitrogenIBA 02/2023
1	Oxygen (Dioxygen)IBA 02/2023
1	VitaminsIBA 01/2023
1	ChromatinIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Sulfur Compounds (Compounds, Sulfur)IBA 01/2023
1	Antimicrobial PeptidesIBA 11/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Therapeutic UsesIBA 01/2021
1	AcrylatesIBA 05/2020
1	2-ethylhexyl acrylateIBA 05/2020
1	PyrroloiminoquinonesIBA 07/2019
1	VemurafenibIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	AminesIBA 10/2018
1	hepsinIBA 10/2018
1	Sulfhydryl Compounds (Thiols)IBA 10/2018
1	HydrogelsIBA 10/2018
1	DisulfidesIBA 10/2018

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2012
3	Chemoprevention 01/2023 - 08/2009
1	Photopheresis 03/2024
1	Blood Component Removal (Apheresis) 03/2024
1	Immunomodulation 06/2023
1	Immunotherapy 03/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2022